Drug
Smofkabiven Extra Nitrogen
Smofkabiven Extra Nitrogen: highest development phase Phase 3, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| SmofKabiven extra Nitrogen NCT05257031 | Phase 3 | Nutrition Therapy |
Latest
No recent events.
Follow Smofkabiven Extra Nitrogen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.